Femara 2,5 mg 30 tablets
Novartis
Novartis
Composition
Active ingredient: letrozole 2.5 mg.
Excipients: lactose monohydrate, microcrystalline cellulose, corn starch, sodium starch glycolate, magnesium stearate, colloidal anhydrous silica, hypromellose (E464), talc, macrogol 8000, titanium dioxide (E171), yellow iron oxide (E172).
Product Description
Femara contains letrozole, an aromatase inhibitor.
It is a hormonal (endocrine) therapy for breast cancer.
Letrozole reduces estrogen levels by blocking the aromatase enzyme, slowing or stopping the growth of estrogen‑dependent tumor cells.
Indications
Treatment of breast cancer in postmenopausal women.
Prevention of breast cancer recurrence.
First‑line therapy before surgery when immediate surgery is not suitable.
Treatment after surgery or after a 5‑year course of tamoxifen.
Prevention of tumor spread in advanced breast cancer.
Method of Administration and Dosage
Take strictly as prescribed by your doctor.
Usual dose: 1 Femara tablet once daily.
Take at the same time each day.
Swallow the tablet whole with water.
Treatment is long‑term — months or years, under regular medical supervision.
In case of overdose — contact a doctor.
If a dose is missed
if the next dose is due in 2–3 hours — skip the missed dose;
otherwise take it as soon as remembered and continue the schedule;
do not double the dose.
Do not stop treatment unless instructed by your doctor.
Side Effects
Very common: hot flushes, increased cholesterol, fatigue, sweating, bone and joint pain.
Common: skin rash, headache, dizziness, nausea, vomiting, dyspepsia, constipation, diarrhea, appetite changes, muscle pain, osteoporosis, swelling, depression, weight gain, hair loss, hypertension, abdominal pain, dry skin, vaginal bleeding, palpitations.
Uncommon: weakness, paralysis, speech disturbances, sudden chest pain, vein inflammation, high fever, mouth ulcers, blurred vision, tendinitis.
Rare: difficulty breathing, fainting, cyanosis, sudden limb pain (thrombosis), tendon rupture.
Other: anxiety, irritability, memory problems, carpal tunnel syndrome, sensory disturbances, eye symptoms, itching, vaginal dryness, high temperature, dry mucous membranes, weight loss, urinary infections, cough, elevated enzymes, jaundice.
Seek medical attention immediately if severe symptoms occur.
Contraindications
Allergy to letrozole or any excipient.
Premenopausal status (menstruation still present).
Pregnancy.
Breastfeeding.
Warnings and Precautions
Severe kidney or liver disease.
Osteoporosis or history of fractures.
Possible tendon inflammation or injury.
Inform your doctor about all medications you take.
Use only after menopause.
Do not use during pregnancy or breastfeeding.
Avoid driving if dizzy or drowsy.
Contains lactose — consult a doctor if intolerant to sugars.
Contains less than 1 mmol sodium — essentially sodium‑free.
May reduce bone density — bone density monitoring may be required.
Inform your doctor about all medicines you are taking, including over‑the‑counter products.
Storage Conditions
Store at temperatures not exceeding 30°C.
Packaging
A carton box containing 3 blister packs of 10 tablets each and a paper leaflet.